Menu
← Oncology Approval Tracker
FDA DECISION ·
Keytruda + chemoradiotherapy
pembrolizumab with chemoradiotherapy · Merck
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Pembrolizumab with chemoradiotherapy for cervical cancer classified as FIGO 2014 stage III–IVA.
LAMPGEN ANALYSIS
Why it matters
The decision brought pembrolizumab into definitive therapy for a specified locally advanced group.
What research teams should watch
Use the stated FIGO edition, then align external beam radiation, brachytherapy, chemotherapy and immunotherapy schedules.
PRIMARY RECORDS